Investor Day Presentations

  • Myriad Genetics: Accelerating Our Transformation and Growth

    Paul J. Diaz

    President & CEO

    Paul J. Diaz

    President & CEO

    • New to Myriad – joined August 2020
    • One of the “100 Most Influential People in Healthcare” & “Top 25 Minority Leaders in Healthcare” – named by Modern Healthcare numerous years
    • Most recently a partner at Cressey & Company – a private equity firm (managing $3 billion in committed capital) with 30+ years of success investing in and helping to build high quality healthcare businesses
    • Former president & chief executive officer & vice chairman of Kindred Healthcare, Inc. which was named one of the “Most Admired healthcare companies in the U.S.” by Fortune for 6 years in a row during Paul’s tenure

  • Executing on A Winning Commercial Strategy

    Eric Santa

    Chief Growth Officer

    Eric Santa

    Chief Growth Officer

    • New to Myriad – Eric joined in April 2021 to accelerate company growth, build new commercial and digital capabilities, and boost market demand
    • Previously, chief revenue officer of Rally Health, Inc., a division of Optum within UnitedHealth Group, where he spearheaded consumer digital health strategies and led key business functions including sales
    • Previously held several other strategy and leadership positions at Optum, The Boston Consulting Group and The Blue Cross and Blue Shield Association
    • Earned a Bachelor’s degree in Economics from Purdue University and a Master’s in Business Administration from The Kellogg School at Northwestern University

  • Enterprise Technology: Capabilities to Better Serve Patients and Providers

    Dr. Kevin R. Haas

    Chief Technology Officer

    Dr. Kevin R. Haas

    Chief Technology Officer

    • Joined Myriad in 2013 – has served in senior level leadership roles across research and development, bioinformatics, engineering and technology
    • Previously was vice president of Bioinformatics
    • Received a B.S. from University of Wisconsin-Madison and a Ph.D. in Chemical Engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics from single molecule fluorescence
    • Has co-authored 16 peer reviewed publications and eight patent applications

  • Driving Product Differentiation and Value through Focused R&D and Data Analytics

    Dr. Jerry Lanchbury

    Chief Scientific Officer

    Dr. Jerry Lanchbury

    Chief Scientific Officer

    • Joined Myriad in 2002
    • Is a highly respected expert in immunogenetics with more than 100 reviewed research journal publications
    • Was a researcher in molecular immunogenetics at Kings College London
    • Graduated from the University of Aston, Birmingham, U.K.
    • Earned a Ph.D. in Population Genetics from the University of Newcastle upon Tyne
    • Completed a postdoctoral fellowship at the United Medical & Dental Schools of the University of London in Human Disease Genetics

  • Expanding our Reach in Hereditary Cancer | Capitalizing on Growth in the Prenatal Market

    Nicole Lambert

    President of Myriad Genetic Laboratories

    Nicole Lambert

    President of Myriad Genetic Laboratories

    • Joined Myriad in 2001 – was previously Myriad’s general manager for Oncology and Urology and vice president of Dermatology
    • Was a genetic counselor at LabCorp prior to Myriad
    • Received a bachelor’s degree in Biology and Sociology from Boston College
    • Earned a master’s in genetic counseling from Mt. Sinai School of Medicine at New York University

  • Building Comprehensive Solutions in Oncology

    Faith Zaslavsky

    President of Oncology

    Faith Zaslavsky

    President of Oncology

    • Joined Myriad in 2000 – has held roles with progressive responsibility in sales, strategic account management and leadership
    • Prior to her current position, she held multiple commercial leadership roles including National Sales Director of Oncology, Regional Sales Director of Women’s Health and Regional Manager of Managed Care
    • Serves on the Board of Directors for non-profit organizations focusing on children’s development and Jewish education
    • Received her bachelor’s degree in Business Administration from Washington State University

  • GeneSight®: Serving Growing Needs in Mental Health

    Mark S. Verratti

    President of Mental Health

    Mark S. Verratti

    President of Mental Health

    • Joined Myriad in 2016
    • Previously, SVP and chief sales & business development officer at Assurex Health
    • Held senior leadership positions with Forest Pharmaceuticals where he led commercial teams with revenues approaching $500 million
    • Held senior and general management positions with Cyberonics/LivaNova leading teams in over 70 countries
    • Received a B.S. in Life Sciences with a minor in Physiology from The Pennsylvania State University

  • Delivering Long-Term Growth and Profitability

    Bryan Riggsbee

    Chief Financial Officer

    Bryan Riggsbee

    Chief Financial Officer

    • Joined Myriad in 2014
    • Previously served 10 years with LabCorp, mostly recently as the senior vice president of Corporate Finance
    • Served in various finance roles with General Electric and the audit division of KPMG
    • Received a B.A. degree in Accounting from North Carolina State University, a B.A. degree in Political Science from the University of North Carolina at Chapel Hill, and an M.B.A. from Northwestern University
    • Certified Public Accountant licensed in the State of North Carolina

  • Summary & Closing Remarks

    Paul J. Diaz

    President & CEO

    Paul J. Diaz

    President & CEO

    • New to Myriad – joined August 2020
    • One of the “100 Most Influential People in Healthcare” & “Top 25 Minority Leaders in Healthcare” – named by Modern Healthcare numerous years
    • Most recently a partner at Cressey & Company – a private equity firm (managing $3 billion in committed capital) with 30+ years of success investing in and helping to build high quality healthcare businesses
    • Former president & chief executive officer & vice chairman of Kindred Healthcare, Inc. which was named one of the “Most Admired healthcare companies in the U.S.” by Fortune for 6 years in a row during Paul’s tenure

  • View Full Investor Day Replay